EXHIBIT 23.1


              CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of SciClone
Pharmaceuticals, Inc. for the registration of 407,610 shares of its common
stock and to the incorporation by reference therein of our report dated January
26, 2001, with respect to the consolidated financial statements and schedule of
SciClone Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for
the year ended December 31, 2000, filed with the Securities and Exchange
Commission.



                                                /s/ Ernst & Young LLP


Palo Alto, California
November 5, 2001